Hypertension pharmacogenomics: in search of personalized treatment approaches
about
Is There a Role for Genomics in the Management of Hypertension?Increased Cardiac Workload in the Upright Posture in Men: Noninvasive Hemodynamics in Men Versus WomenPharmacogenetic Associations of β1-Adrenergic Receptor Polymorphisms With Cardiovascular Outcomes in the SPS3 Trial (Secondary Prevention of Small Subcortical Strokes).Personalized medicine: Genetic risk prediction of drug response.Genome-Wide and Gene-Based Meta-Analyses Identify Novel Loci Influencing Blood Pressure Response to Hydrochlorothiazide.Cardiovascular pharmacogenetics: a promise for genomically-guided therapy and personalized medicine.Aliskiren improves endothelium-dependent relaxation of thoracic aorta by activating PI3K/Akt/eNOS signal pathway in SHR.Replicated evidence for aminoacylase 3 and nephrin gene variations to predict antihypertensive drug responses.Personalized medicine-a modern approach for the diagnosis and management of hypertension.Pharmacogenetics in Cardiovascular Medicine.Genetic Variants Associated With Uncontrolled Blood Pressure on Thiazide Diuretic/β-Blocker Combination Therapy in the PEAR (Pharmacogenomic Evaluation of Antihypertensive Responses) and INVEST (International Verapamil-SR Trandolapril Study) Trials.Effects of four different antihypertensive drugs on plasma metabolomic profiles in patients with essential hypertension.Antihypertensive therapy in pre-eclampsia: effects of plasma from nonresponsive patients on endothelial gene expression.Gene-Gene Interactions Among PRKCA, NOS3 and BDKRB2 Polymorphisms Affect the Antihypertensive Effects of Enalapril.Pharmacogenomics of Hypertension and Preeclampsia: Focus on Gene-Gene Interactions.
P2860
Q33838442-3441B77A-72DE-42DD-968D-7712DA206683Q37076066-1374F44A-F0B9-4DEF-A3F6-08F0A1332F68Q38378871-E1FA85A7-0391-4F14-A8F7-2F005BEF5046Q38756015-0E43F81C-DB8F-49D6-95C8-AD3AFD34A31CQ38801250-C7A477C8-E9CF-4CDC-B160-4AFC39E630DFQ38974781-F2A92BF2-E4AC-4A1A-9F11-86E6336AC9D8Q40067806-0A61BF75-1D92-4D77-8F72-D017185C6869Q40269056-AE6C151E-0B93-4FFA-A049-3C102BDB1AB6Q47095825-5F5BCE27-D376-4785-8E39-63470753BF73Q47130405-14D5E106-F066-4345-8E15-CA730AC02FC2Q47137466-0269A824-6EC1-4107-828F-CF96D488D7ADQ47168939-45598F92-9C6A-45E4-B05F-6124D6E8415AQ51277499-836E989A-8160-478D-ADF3-80058FBB0EEAQ51437723-3CD1B96E-346A-4B2A-8F65-9682AD23E71CQ52355222-9B01E826-16B1-43CF-A304-80AEC274B3E5
P2860
Hypertension pharmacogenomics: in search of personalized treatment approaches
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
2015年论文
@zh
2015年论文
@zh-cn
name
Hypertension pharmacogenomics: in search of personalized treatment approaches
@ast
Hypertension pharmacogenomics: in search of personalized treatment approaches
@en
type
label
Hypertension pharmacogenomics: in search of personalized treatment approaches
@ast
Hypertension pharmacogenomics: in search of personalized treatment approaches
@en
prefLabel
Hypertension pharmacogenomics: in search of personalized treatment approaches
@ast
Hypertension pharmacogenomics: in search of personalized treatment approaches
@en
P2860
P356
P1476
Hypertension pharmacogenomics: in search of personalized treatment approaches
@en
P2093
Julie A Johnson
Rhonda M Cooper-DeHoff
P2860
P2888
P304
P356
10.1038/NRNEPH.2015.176
P407
P577
2015-11-23T00:00:00Z